1. A rapid point-of-care assay accurately measures vitamin D
- Author
-
J Lotz, K Albrecht, George J. Kahaly, Lara Frommer, and Karl J. Lackner
- Subjects
medicine.medical_specialty ,Point-of-Care Systems ,Endocrinology, Diabetes and Metabolism ,Vitamin D serum levels ,610 Medizin ,Urology ,Fluorescent Antibody Technique ,Chemiluminescence assay ,Endocrinology ,610 Medical sciences ,Vitamin D and neurology ,Humans ,Medicine ,Rapid On-site Evaluation ,Cholecalciferol ,Point of care ,Laboratory methods ,Rapid assay ,business.industry ,Immunofluorescence assay ,Reproducibility of Results ,Vitamin D Deficiency ,Serum samples ,Clinical Practice ,Absolute deviation ,Dimensional Measurement Accuracy ,Point-of-care ,Luminescent Measurements ,Original Article ,Linear correlation ,business - Abstract
Purpose Vitamin D (VitD) is a pleiotropic hormone with effects on a multitude of systems and metabolic pathways. Consequently, the relevance of a sufficiently high VitD serum level becomes self-evident. Methods A rapid immunofluorescence assay designed for the point-of-care measurement of serum VitD3 solely was tested. Inter- and intra-assay validation, double testing and result comparison with a standardized laboratory method were performed. Results An overall linear correlation of r = 0.89 (Pearson, 95% CI 0.88–0.92, p r = 0.91, 95% CI 0.86–0.94, p r = 0.86, 0.82–0.89, p Conclusion This novel, innovative, and controlled study indicates that the evaluated rapid point of care VitD assay is reliable, accurate, and suited for clinical practice.
- Published
- 2021
- Full Text
- View/download PDF